Drug intelligence / Profile preview

[Dmt1, D-2-Nal4]endomorphin-1

Development stage
Preclinical
Lead developer
Medical University of Lodz
Modality
Peptides
01

Overview

[Dmt1, D-2-Nal4]endomorphin-1 is a synthetic tetrapeptide analogue of the endogenous opioid endomorphin-1. It is modified with 2',6'-dimethyl-L-tyrosine (Dmt) at the first position and D-2-naphthylalanine (D-2-Nal) at the fourth position. Unlike the parent peptide, which is a potent mu-opioid receptor (MOR) agonist, this modified analogue functions as a selective MOR antagonist. Preclinical research has demonstrated that [Dmt1, D-2-Nal4]endomorphin-1 can up-regulate MOR gene expression and inhibit the proliferation of MCF-7 breast cancer cells, suggesting its utility as a research tool for investigating opioid signaling pathways and their role in tumor biology.

Other names
[Dmt1, D-2-Nal4]EM-1Dmt-Pro-Trp-D-2-Nal-NH2Dmt-Pro-Trp-D2-Nal-NH2Dmt-Pro-Trp-D 2-Nal-NH2
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on [Dmt1, D-2-Nal4]endomorphin-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [Dmt1, D-2-Nal4]endomorphin-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call